These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 26013593)

  • 21. Cell surface receptor-antibody association constants and enumeration of receptor sites for monoclonal antibodies.
    Siiman O; Burshteyn A
    Cytometry; 2000 Aug; 40(4):316-26. PubMed ID: 10918282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of leucocyte antibody binding capacity (ABC): the need for standardization.
    Barnett D; Storie I; Wilson GA; Granger V; Reilly JT
    Clin Lab Haematol; 1998 Jun; 20(3):155-64. PubMed ID: 9681230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The ISCCA flow protocol for the monitoring of anti-CD20 therapies in autoimmune disorders.
    Gatti A; Buccisano F; Scupoli MT; Brando B
    Cytometry B Clin Cytom; 2021 Mar; 100(2):194-205. PubMed ID: 32598578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison between CD19 and CD20 expression patterns on acute leukemic cells.
    Ning BT; Tang YM; Chen YH; Shen HQ; Qian BQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):943-7. PubMed ID: 16403255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Tumor Microenvironment Regulates CD19 and CD20 Immunotherapy for Lymphoma.
    Lykken JM; Tedder TF
    Cancer J; 2015; 21(4):351-6. PubMed ID: 26222089
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antigen modulation followed by quantitative flow cytometry of B-chronic lymphocytic leukemia cells after treatment.
    Kusenda J; Babusíková O
    Neoplasma; 2004; 51(2):97-102. PubMed ID: 15190418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autoreactive CD19+CD20- Plasma Cells Contribute to Disease Severity of Experimental Autoimmune Encephalomyelitis.
    Chen D; Ireland SJ; Davis LS; Kong X; Stowe AM; Wang Y; White WI; Herbst R; Monson NL
    J Immunol; 2016 Feb; 196(4):1541-9. PubMed ID: 26764035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of CD19 and CD20 peptides for induction of antigen-specific CTLs against B-cell malignancies.
    Bae J; Martinson JA; Klingemann HG
    Clin Cancer Res; 2005 Feb; 11(4):1629-38. PubMed ID: 15746068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved four-color flow cytometry method using fluo-3 and triple immunofluorescence for analysis of intracellular calcium ion ([Ca2+]i) fluxes among mouse lymph node B- and T-lymphocyte subsets.
    Greimers R; Trebak M; Moutschen M; Jacobs N; Boniver J
    Cytometry; 1996 Mar; 23(3):205-17. PubMed ID: 8974866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dual-labelled antibodies for flow and mass cytometry: A new tool for cross-platform comparison and enrichment of target cells for mass cytometry.
    Baumgart S; Schulz AR; Peddinghaus A; Stanislawiak S; Gillert S; Hirseland H; Krauthäuser S; Dose C; Mei HE; Grützkau A
    Eur J Immunol; 2017 Aug; 47(8):1377-1385. PubMed ID: 28654217
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative analysis of different permeabilization methods for the flow cytometry measurement of cytoplasmic myeloperoxidase and lysozyme in normal and leukemic cells.
    Lanza F; Latorraca A; Moretti S; Castagnari B; Ferrari L; Castoldi G
    Cytometry; 1997 Jun; 30(3):134-44. PubMed ID: 9222099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantification of cells with specific phenotypes I: determination of CD4+ cell count per microliter in reconstituted lyophilized human PBMC prelabeled with anti-CD4 FITC antibody.
    Stebbings R; Wang L; Sutherland J; Kammel M; Gaigalas AK; John M; Roemer B; Kuhne M; Schneider RJ; Braun M; Engel A; Dikshit DK; Abbasi F; Marti GE; Sassi MP; Revel L; Kim SK; Baradez MO; Lekishvili T; Marshall D; Whitby L; Jing W; Ost V; Vonsky M; Neukammer J
    Cytometry A; 2015 Mar; 87(3):244-53. PubMed ID: 25655255
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD4 T-lymphocyte determinations on whole blood specimens using a single-tube three-color assay.
    Nicholson JK; Jones BM; Hubbard M
    Cytometry; 1993; 14(6):685-9. PubMed ID: 8104771
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
    Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discordant expression of CD20 by flow cytometry and immunohistochemistry in a patient responding to rituximab: an unusual mechanism.
    Walsh KJ; Al-Quran SZ; Li Y; Braylan RC; Lynch JW
    Clin Lymphoma Myeloma; 2007 Jan; 7(4):319-22. PubMed ID: 17324342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of dry blood spot technique for quantification of an Anti-CD20 monoclonal antibody drug in human blood samples.
    Lin YQ; Zhang Y; Li C; Li L; Zhang K; Li S
    J Pharmacol Toxicol Methods; 2012 Jan; 65(1):44-8. PubMed ID: 22178408
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Characteristics of 4 specific target antigens in adult acute lymphoblastic leukemia].
    Lin ZK; Zhang R; Ge Z; Liu J; Wu YJ; Guo X; Qiao C; Qiu HR; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):289-95. PubMed ID: 23628018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A combined HIV-1 protein bead array for serology assay and T-cell subset immunophenotyping with a hybrid flow cytometer: a step in the direction of a comprehensive multitasking instrument platform for infectious disease diagnosis and monitoring.
    Faucher S; Martel A; Sherring A; Bogdanovic D; Malloch L; Kim JE; Bergeron M; Sandstrom P; Mandy FF
    Cytometry B Clin Cytom; 2006 May; 70(3):179-88. PubMed ID: 16615079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Higher levels of surface CD20 expression on circulating lymphocytes compared with bone marrow and lymph nodes in B-cell chronic lymphocytic leukemia.
    Huh YO; Keating MJ; Saffer HL; Jilani I; Lerner S; Albitar M
    Am J Clin Pathol; 2001 Sep; 116(3):437-43. PubMed ID: 11554173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phenotypic characterization of infiltrating leukocytes in benign prostatic hyperplasia.
    Theyer G; Kramer G; Assmann I; Sherwood E; Preinfalk W; Marberger M; Zechner O; Steiner GE
    Lab Invest; 1992 Jan; 66(1):96-107. PubMed ID: 1370561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.